David Hanlon, Vice President, Assay Services directs a multidisciplinary team and oversees the successful execution of client programs across vaccine and therapeutic applications. He brings over 20 years of industry experience in the diagnostics and life science markets, with a track record of building and scaling laboratory service organizations, establishing strategic partnerships, and driving the global adoption of innovative technologies and platforms. Throughout his career, David has led initiatives spanning product development, program management, strategic marketing, and business and technology assessment. He has built and guided high-performing teams across a range of organizations, including Quanterix, Vizgen, NanoView Biosciences, and Hologic. David holds a B.S. in Biochemistry from Worcester Polytechnic Institute and a Ph.D. from the University of Illinois, Urbana-Champaign.